Nomadic Lactobacilli as cell factory for antibiofilm therapy. [PDF]
Front Cell Infect MicrobiolPaul LS +6 more
europepmc +1 more source
Species Distribution, Characterization, and Antifungal Susceptibility Patterns of <i>Candida</i> Isolates Causing Oral and Vulvovaginal Candidiasis in Chile. [PDF]
Antibiotics (Basel)Nahuelcura F, Duarte EÁ.
europepmc +1 more source
Study on the impact of biofilm formation by <i>Candida albicans</i> in recurrent vulvovaginal candidiasis on drug susceptibility. [PDF]
Front Cell Infect MicrobiolLi S, Shen Z, Wang S, Peng Y, Qi W.
europepmc +1 more source
Sodium-glucose co-transporter inhibitors, refractory hypomagnesaemia and recurrent genital mycotic infections. [PDF]
Clin Kidney JShah CV.
europepmc +1 more source
From microscopy to molecular diagnostics: identifying the complexities of clinical diagnostics for vaginal infections. [PDF]
Microbiol SpectrAmerson-Brown MH.
europepmc +1 more source
HWP1 Gene Sequence Diversity and Antifungal Susceptibility Patterns in Colombian Vulvovaginal Isolates of the <i>Candida albicans</i> Species Complex. [PDF]
Int J MicrobiolMorales-López S +5 more
europepmc +1 more source
Candidiasis epidemiology and outcomes including emergence of <i>Candida auris</i> from a large, Southern US metro area: a six-year evaluation. [PDF]
Antimicrob Steward Healthc EpidemiolHuynh-Phan R +9 more
europepmc +1 more source
Real-World Ibrexafungerp Use Patterns Among Patients with Commercial Health Insurance, United States, 2021-2023. [PDF]
Drugs Real World OutcomesBenedict K, Smith DJ, Gold JAW.
europepmc +1 more source
Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis [PDF]
core +1 more source
Virulence factors, biofilm formation and antifungal resistance in Candida albicans from recurrent vulvovaginal candidiasis patients: a comparative study. [PDF]
Sci RepYan C, Zhang J, Yang Y, Zeng X, Xiao G.
europepmc +1 more source